Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study ; volume:240 ; number:7 ; day:24 ; month:5 ; year:2023 ; pages:1547-1560 ; date:7.2023
Psychopharmacology ; 240, Heft 7 (24.5.2023), 1547-1560, 7.2023
- Creator
-
Breeksema, Joost J.
Niemeijer, Alistair
Kuin, Bouwe
Veraart, Jolien
Vermetten, Eric
Kamphuis, Jeanine
Brink, Wim van den
Schoevers, Robert
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00213-023-06388-6
- URN
-
urn:nbn:de:101:1-2023092113012662000831
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Breeksema, Joost J.
- Niemeijer, Alistair
- Kuin, Bouwe
- Veraart, Jolien
- Vermetten, Eric
- Kamphuis, Jeanine
- Brink, Wim van den
- Schoevers, Robert
- SpringerLink (Online service)
Other Objects (12)
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders : a case report
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
A Novel Treatment Approach to Treatment-Resistant, Recurrent Clostridium difficile
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Treatment-resistant depression: molecular mechanisms and management
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders : a case report
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
A Novel Treatment Approach to Treatment-Resistant, Recurrent Clostridium difficile
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Treatment-resistant depression: molecular mechanisms and management
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders : a case report
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
A Novel Treatment Approach to Treatment-Resistant, Recurrent Clostridium difficile
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment